BVCF (Bioveda China Fund)
Status
ACTIVE
Global HQ
Amsterdam, Netherlands
Countries of investment
- USA
- Germany
- Switzerland
- Singapore
Investment stages
- Seed
- Series A
Industries
- Real Estate
- Construction Tech
- Sustainability
About
BVCF, Founded in 2005 by Dr. Zhi Yang, is a leading biomedical venture Capital firm dedicated to investing in life sciences and healthcare. BVCF has a robust portfolio of nearly 50 companies and manages assets totaling $722 million. The fund emphasizes forwardlooking investment strategies that Capitalize on Technology, policy, and market opportunities.
BVCF, Founded in 2005 by Dr. Zhi Yang, is a leading biomedical venture Capital firm dedicated to investing in life sciences and healthcare. BVCF has a robust portfolio of nearly 50 companies and manages assets totaling $722 million. The fund emphasizes forwardlooking investment strategies that Capitalize on Technology, policy, and market opportunities.
Investment Thesis
BVCF focuses on creating and developing innovative global Chinese life sciences companies. The fund aims to build transformative healthcare companies by leveraging its deep industry knowledge and strategic insights.
Portfolio
Solicitude Medical Technology
Seinda
Oculis Holding
Cellenkos
Oculis Holding
Wekair
Drug Farm
Boan Biotech
DTRM Biopharma
MaxiNovel Pharmaceuticals